|
TTK expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.47548639972683E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.241330E-03 |
| Normal-vs-Stage2 |
3.131600E-02 |
| Normal-vs-Stage3 |
1.208390E-04 |
| Normal-vs-Stage4 |
2.250100E-02 |
| Stage1-vs-Stage2 |
7.993600E-01 |
| Stage1-vs-Stage3 |
3.219200E-03 |
| Stage1-vs-Stage4 |
8.442400E-03 |
| Stage2-vs-Stage3 |
8.056800E-03 |
| Stage2-vs-Stage4 |
9.080000E-02 |
| Stage3-vs-Stage4 |
9.640600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.09129999481539E-08 |
| Normal-vs-AfricanAmerican |
7.234500E-04 |
| Normal-vs-Asian |
4.605500E-02 |
| Caucasian-vs-AfricanAmerican |
6.173600E-01 |
| Caucasian-vs-Asian |
2.826200E-01 |
| AfricanAmerican-vs-Asian |
1.290760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.17940110402992E-11 |
| Normal-vs-Female |
1.998550E-04 |
| Male-vs-Female |
6.538200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.938100E-03 |
| Normal-vs-Extreme_Weight |
1.63990000023873E-07 |
| Normal-vs-Obese |
2.47589999999853E-05 |
| Normal-vs-Extreme_Obese |
7.194300E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.745600E-02 |
| Normal_Weight-vs-Obese |
9.613200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.499300E-03 |
| Extreme_Weight-vs-Obese |
2.512300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.002120E-02 |
| Obese-vs-Extreme_Obese |
6.029200E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.675800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.43849999689749E-08 |
| Normal-vs-Age(61-80Yrs) |
2.786300E-04 |
| Normal-vs-Age(81-100Yrs) |
3.438700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.750200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.969900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.804100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.168800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.809800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.529400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.32739996772102E-09 |
| Normal-VS-Type2 PRCC |
1.78946999999097E-05 |
| Normal-VS-KIRP CIMP |
2.203600E-03 |
| Normal-VS-Unclassified PRCC |
2.621500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.817600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
4.304500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
6.780200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.249940E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.949600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.919900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.97640000000532E-05 |
| Normal-vs-N1 |
1.56687999999239E-05 |
| Normal-vs-N2 |
1.987180E-01 |
| N0-vs-N1 |
2.412600E-04 |
| N0-vs-N2 |
3.707000E-01 |
| N1-vs-N2 |
1.777150E-01 |
|
|
